Cost-effectiveness of Polypills, Obesity and FH, Adverse Pregnancy Outcomes and Long-term HF Risk
In this week’s View, Dr. Eagle examines the cost-effectiveness of polypills. He then discusses overweight and obesity in patients with familial hyperlipidemia. Finally, Dr. Eagle explores how adverse pregnancy outcomes are associated with long-term risk of heart failure.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Atherosclerotic Disease (CAD/PAD), Lipid Metabolism, Nonstatins, Primary Hyperlipidemia, Acute Heart Failure, Hypertension, Acute Coronary Syndromes, Valvular Heart Disease, Vascular Medicine
Keywords: Cost of Illness, Health Equity, Cost-Benefit Analysis, Cholesterol, LDL, Coronary Artery Disease, Hyperlipoproteinemia Type II, Obesity, Hypertension, Diabetes, Gestational, Pregnancy Outcome, Pre-Eclampsia, Premature Birth, Heart Disease Risk Factors, Heart Failure
